Article List

WPRIM Management System> DCMS> Clinical and Molecular Hepatology> 2017> 23> 2

Volume: 23 Issue: 2

1. Development of autoimmune hepatitis in a psoriasis patient without immunosuppressive therapy.	Page:184—187
2. A case of ruptured hepatic angiomyolipoma in a young male.	Page:179—183
3. Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B.	Page:170—178
4. Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion.	Page:160—169
5. Clinical impact of the early alanine amininotransferase flare during tenofovir monotherapy in treatment-naïve patients with chronic hepatitis B.	Page:154—159
6. Acute hepatitis A, B and C but not D is still prevalent in Mongolia: a time trend analysis.	Page:147—153
7. Meta-analysis of the correlation between the rs17401966 polymorphism in kinesin family member 1B and susceptibility to hepatitis B virus related hepatocellular carcinoma.	Page:138—146
8. A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function.	Page:128—137
9. Is alanine aminotransferase flare-up in nucleos(t)ide analogue treatment of chronic hepatitis B a promising, rather than a devastating, sign?.	Page:125—127
10. Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?.	Page:123—124
11. Life-sustaining treatment and palliative care in patients with liver cirrhosis - legal, ethical, and practical issues.	Page:115—122
12. Radioembolization for the treatment of hepatocellular carcinoma.	Page:109—114
13. NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs.	Page:103—108